Ketamine Therapy for Traumatic Brain Injury: Complete Guide

If you're recovering from a traumatic brain injury (TBI), or caring for someone who is, you've probably noticed that the hardest part isn't always the injury itself. It's the depression, anxiety, and post-traumatic stress disorder (PTSD) that settle in afterward and refuse to lift, even with medication and therapy.

The bottom line: Ketamine does not treat brain injury, repair damaged tissue, or slow recovery. But for post-TBI depression, anxiety, or PTSD that haven't responded to standard antidepressants, ketamine may offer relief through a different mechanism. The evidence for this specific use is still early, with no completed randomized controlled trial in people with TBI, though the broader research on ketamine for treatment-resistant depression is strong.

Innerwell offers at-home ketamine therapy with clinical oversight built in, so you can explore whether it's right for your situation without adding more clinic visits to an already full recovery schedule.

How Brain Injury Affects Mental Health

Roughly 5.3 million people in the U.S. live with TBI-related disabilities. Even injuries classified as mild can affect mood, memory, and concentration long after the initial event, and when those symptoms persist for weeks or months, the depression and anxiety that come with them are often the hardest part to treat.

Up to half of survivors experience clinically significant depression within two years of injury, and among those with post-TBI depression, 60% also develop a comorbid anxiety disorder. PTSD affects roughly 15.6% of civilians with TBI and an estimated 48.8% of military service members with a military-related TBI, according to one meta-analysis.

These aren't character flaws or failure to cope. They're biological consequences of injury to the brain, and they deserve real treatment.

Traditional Treatments and Their Limitations

If you've tried selective serotonin reuptake inhibitors (SSRIs) or other antidepressants and felt like they weren't doing much, you're not imagining it. The medications that work reasonably well for depression in the general population often fall short after a brain injury.

Multiple systematic reviews have failed to find definitive evidence that any specific antidepressant class reliably helps post-TBI depression, and a high-quality trial of sertraline found no significant difference from placebo.

The reason may come down to what's happening inside the injured brain. After TBI, inflammatory activity ramps up and can stay elevated for months or even years. That neuroinflammation appears to blunt how well SSRIs work.

In an animal model, fluoxetine alone produced no antidepressant effect after brain injury, but paired with an anti-inflammatory agent, nearly all depressive markers disappeared. Your brain after TBI isn't the same brain the medications were designed for, and that mismatch explains a lot of what you may have experienced.

This treatment gap is a big reason researchers began looking at ketamine, which works through an entirely different system.

How Does Ketamine Therapy Work?

Ketamine works differently from every standard antidepressant. While SSRIs adjust serotonin over weeks, ketamine acts on the brain's glutamate system within hours.

1. Stage 1: Releasing the brake. Ketamine temporarily blocks N-methyl-D-aspartate (NMDA) receptors, which briefly increases glutamate release in the brain.
2. Stage 2: A glutamate surge. That extra glutamate stimulates AMPA receptors, another set of receptors in the same signaling system.
3. Stage 3: Growth signals switch on. AMPA activation triggers the release of brain-derived neurotrophic factor (BDNF), a protein that supports neuron survival and encourages growth of new ones.
4. Stage 4: New connections form. BDNF activates mTOR, a pathway that helps form fresh synaptic connections. This process is the same neuroplasticity the brain uses to rebuild after injury.

This mechanism matters especially for brain injury, because BDNF runs low in both depression and TBI. A brain injury compromises BDNF signaling and increases cell death in the hippocampus, and the inflammatory cytokines that spike after injury suppress BDNF further. Ketamine also acts directly against that inflammation.

It reduces microglial activation and lowers cytokines like IL-6 and TNF-alpha. Whether these mechanisms translate into reliable benefit for people with TBI is a separate question, and the honest answer is that the evidence isn't there yet.

What Does the Research Show?

No completed randomized controlled trial has tested ketamine for depression specifically in people with TBI. As one review puts it, this treatment has not been formally tested for that indication.

For treatment-resistant depression broadly, the evidence is strong, with response rates exceeding 50% and remission rates between 30% and 50%. What's more useful for your situation, though, is the data from populations that overlap with TBI.

In one small open-label study of 15 veterans with PTSD and treatment-resistant depression, 80% reached PTSD remission after six ketamine infusions over two weeks. That's a striking number, though the small sample size and lack of blinding mean it needs confirmation.

People with comorbid neuropathic pain, common after brain injury, saw greater improvement with ketamine than those with depression alone.

But the closest real-world data in people with TBI gives reason for caution. A 2025 VA San Diego study found that ketamine and esketamine produced no improvement in depression symptoms among veterans with comorbid TBI and severe obstructive sleep apnea.

That subgroup is specific, so results may not apply broadly, but they should temper expectations. And a 2024 Johns Hopkins commentary warned that for off-label psychiatric uses of ketamine, "enthusiasm and marketing have gotten ahead of the evidence." Data on how ketamine affects cognition in neurological disease remains limited, with evidence isolated to animals and inconclusive.

Better answers may be coming. A Phase 2 trial is testing intravenous (IV) ketamine against midazolam for PTSD and major depression specifically in people with TBI. A separate multi-center trial at Northwestern University, now recruiting, is comparing ketamine, stellate ganglion blocks, and combination treatment for TBI-associated headaches and PTSD.

Results from these studies could clarify whether the promising signals from adjacent populations hold up in people with brain injuries.

What risks should you know about?

People with TBI face a few concerns that don't apply to everyone:

• Intracranial pressure (ICP). In the 1970s, ketamine was avoided in neuro-ICUs based on two small studies suggesting it raised ICP. Modern evidence has largely overturned that finding, and the Neurocritical Care Society now lists ketamine among sedation options for intracranial hypertension. Still, the FDA label advises caution in people with elevated cerebrospinal fluid pressure, so any history of raised ICP needs clinical review.
• Cognitive and dissociative effects. Ketamine's acute dissociative effects, including hallucinations and confusion, can be disruptive in people with pre-existing cognitive difficulties and may worsen those difficulties or trigger delirium. If you or your loved one already deals with memory gaps or confusion from the injury, understanding what it feels like ahead of time helps you prepare.
• Cardiovascular effects. Ketamine raises blood pressure and heart rate. Roughly 30% of participants in one study of 205 infusions showed transient changes. IV ketamine is contraindicated where elevated blood pressure poses serious risk, and esketamine is contraindicated in aneurysmal vascular disease, arteriovenous malformation, and hemorrhage.
• Off-label status. Ketamine is FDA-approved only as an anesthetic. Esketamine carries psychiatric approval for treatment-resistant depression. Neither is approved specifically for TBI-associated depression.

How Innerwell's At-Home Ketamine Therapy Works

For people it helps, improvement rarely feels dramatic. The heaviness starts to lift. Mornings get a little easier. The constant background dread quiets down, and small things stop feeling impossible. The goal is enough relief to reengage with rehab, with people you care about, and with daily life.

Innerwell's clinical team helps you find out whether at-home ketamine therapy could get you there, and supports you through each step if it's a fit.

The process:

1. Full clinical evaluation. A clinician reviews your full medical and psychiatric history, including your injury details, any history of elevated ICP or seizures, and cardiovascular conditions. If you have a caregiver or family member involved in your recovery, their input is genuinely valuable here. They often notice mood and cognitive patterns that are hard to see from the inside.
2. Secure at-home medication delivery. Once you're cleared, Innerwell ships sublingual ketamine tablets to your home. If cognitive impairment is significant, a supervised clinical setting may be more appropriate, and your clinician will be straightforward about that. The at-home option applies when the evaluation confirms it fits.
3. Guided preparation and integration therapy. You complete clinician-guided sessions at home, with a responsible adult present for each session and remote clinical support available. Ketamine can open a door, but integration therapy is how you actually walk through it. It helps you turn a temporary shift in mood into lasting change.
4. Ongoing monitoring and dosage adjustment. Your care team refines the plan over time based on how you respond, and coordinates with your neurologists and rehabilitation providers so everyone is working from the same page.

Program outcomes: Across Innerwell's general depression and anxiety program, people report a 69% reduction in depression symptoms and a 60% reduction in anxiety symptoms after 10 weeks, with 87% seeing improvement within 4 weeks and an average rating of 4.7 out of 5. These figures reflect the broader treatment population, not people with TBI specifically.

Pricing: Innerwell's care starts at $54 per session with insurance. Coverage varies by plan, and Innerwell confirms your specific benefits during the assessment.

Is Ketamine Therapy Right for Me?

You're more likely to be a good candidate if you've been diagnosed with depression, anxiety, or PTSD after a brain injury, you've given standard antidepressants a real try without enough relief, and you're stable enough medically and cognitively to participate in at-home treatment safely.

The overlap between post-TBI depression, treatment resistance, and comorbid pain is exactly the territory where ketamine has shown the most promise in adjacent research. Veterans and service members dealing with post-TBI PTSD fall squarely in this overlap. Risk factors that affect candidacy are worth understanding as you explore your options.

You'll want to have an honest conversation with a clinician first if you have a history of elevated intracranial pressure, serious cardiovascular risk, psychosis, active substance use disorder, or significant cognitive impairment.

Because the evidence for this specific population is still limited, a program that screens carefully is one you can trust more, not less.

Take the First Step

If post-injury depression or anxiety has held on despite everything you've tried, it's worth finding out whether ketamine therapy fits your situation. Take the free assessment to learn about the right treatment path for you, with clinicians who take your brain injury history into account from the start.

Frequently Asked Questions

Can ketamine repair brain injury or slow TBI progression?

No. Ketamine is being explored for post-injury mood symptoms, not as a treatment for the injury itself. It will not repair brain tissue or change the course of recovery. Animal research has suggested some neuroprotective potential, but that hasn't been established in humans.

How are safety considerations different after a brain injury?

The biggest difference is that your brain is already dealing with inflammation, possible cognitive changes, and potentially altered pressure dynamics. A clinician evaluating you for ketamine after TBI will look at things that might not come up for someone without a brain injury history: how recent the injury was, whether you've had any issues with intracranial pressure, how significant any cognitive changes are, and whether dissociative side effects could be harder for you to manage. Innerwell's evaluation covers all of this before determining candidacy.

Will ketamine work if antidepressants didn't help my post-TBI depression?

It might. Ketamine works through the glutamate system rather than serotonin, so the factors that can make SSRIs less effective after brain injury don't necessarily apply. But TBI-specific evidence is still limited, and results vary from person to person.

How long does it take to work?

Faster than SSRIs. Ketamine can start shifting mood within hours rather than the weeks a standard antidepressant takes, and some people notice a lift after a single session. Lasting change usually takes a structured course over several weeks, with integration therapy helping the early gains hold.

Can family caregivers of people with TBI receive ketamine therapy too?

Yes. Caregivers face high rates of depression and anxiety themselves, with studies showing up to half report elevated distress. If you're caring for someone with a brain injury and your own mental health is suffering, ketamine therapy for treatment-resistant depression is available to adults who qualify. A separate assessment would determine your candidacy.